Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

• Status: Not yet recruiting
• Trial end date: 2024-10-01
• Target enrollment: 0
• Participant gender: All

Summary

ALB-TRIAL

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aleksander Krag
• Collaborator: EASL - CLIF Consortium

Criteria

Inclusion Criteria:

• ...

Exclusion Criteria:

• ...